MW 145.16 Da, Purity >99%. RNA synthesis inhibitor. Displays antimicrobial activity and also shows chelating properties. Active in vivo.
28 kDa heat shock protein, A830040C14Rik, A930035J23Rik, ACLS, AI047573, AI838772, AIS, AL024412, ANDR_HUMAN, AP-1, APOPAIN, AR, AR8, ARO, ARO1, AU014659,, AW493413, Activator protein 1, Amp2, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), Antigen NY-CO-13, Apoptotic protease Mch-3, Aromatase, Atherosclerosis, susceptibility to, included, BAZ2B_HUMAN, BCC7, BXR, Bromodomain adjacent to zinc finger domain 2B, Bromodomain adjacent to zinc finger domain protein 2B, CAR, CAR BETA, CARA, CASP3_HUMAN, CASP7_HUMAN, CC3, CMH-1, CMT2F, COMT_HUMAN, CP19A_HUMAN, CPP-32, CPP32B, CPV1, CYAR, CYP19, CYPXIX, Car 1, Casp3a, Caspase 3, apoptosis-related cysteine peptidase, Caspase 3, apoptosis-related cysteine protease, Caspase 3, apoptosis-related cysteine protease a, Caspase 7, Caspase 7 apoptosis related cysteine peptidase, Caspase-3, Caspase-3 subunit p12, Caspase-7 subunit p11, Catechol O-methyltransferase, Cellular tumor antigen p53, Constitutive activator of retinoid response, Constitutive active response, Constitutive androstane receptor, Cyp19a1, Cysteine protease CPP32, Cytochrome P-450AROM, Cytochrome P450 19A1, Cytochrome P450, family 19, subfamily A, polypeptide 1, Cytochrome P450, subfamily XIX (aromatization of androgens), DHTR, DKFZp434H071, DKFZp586P1322, DKFZp686N23123, DKFZp762I0516, DNA binding protein, Dihydro testosterone receptor, Dihydrotestosterone receptor (DHTR), EC 2.1.1.6, EC 3.4.22.56, EIF 2 associated p67 homolog, EIF-2-associated p67, ER, ER-alpha, ER-beta, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESRA, ESRL 1, ESRR A, ESTR B, Enhancer Binding Protein AP1, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta 4, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen resistance, included, Estrogen synthase, Estrogen synthetase, Estrogen-regulated 24 kDa protein, Estrogen-related receptor alpha, Estrra, FLJ11090, FLJ45644, FLJ92943, GCCR, GCPS, GCRST, GCR_HUMAN, GLI Kruppel family member GLI 3, GLI Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome), GLI family zinc finger 3, GLI3 C-terminally truncated form, GLI3 form of 190 kDa, GLI3 form of 83 kDa, GLI3 full length protein, GLI3-190, GLI3-83, GLI3FL, GLI3_HUMAN, GR, Glioma associated oncogene family zinc finger 3, Glucocorticoid receptor, Grl1, HDL cholesterol, augmented response of, to hormone replacement, included, HEL-S-102, HMN2B, HS.76067, HSP 27, HSPB1_HUMAN, HUMARA, HYSP1, Heat Shock Protein 27, Heat shock 25kDa protein 1, Heat shock 27 kDa protein, Heat shock 27kD protein 1, Heat shock 27kDa protein 1, Heat shock 28kDa protein 1, Heat shock protein beta-1, Hsp 25, Hsp 28, ICE-LAP3, ICE-like apoptotic protease 3, ICE3, IMD42, Initiation factor 2-associated 67 kDa glycoprotein, JUN protein, JUNC, JUN_HUMAN, Jun Activation Domain Binding Protein, Jun oncogene, Jun proto oncogene, KD, Kennedy disease (KD), LFS1, LICE, LICE2, MAP2_HUMAN, MB67, MCH3, MGC102452, MGC104252, MGC104309, MGC112732, MGC127390, MGC129539, MGC53792, MGC97144, MNPEP, MetAP 2, Methionine aminopeptidase 2, Methionyl aminopeptidase 2, Microsomal monooxygenase, Mutant tumor protein 53, Myocardial infarction, susceptibility to, included, NR1F3, NR1I2_HUMAN, NR1I3_HUMAN, NR3A1, NR3A2, NR3B1, NR3C4, Nuclear receptor ROR-gamma, Nuclear receptor RZR-gamma, Nuclear receptor subfamily 1 group F member 3, Nuclear receptor subfamily 1 group I member 2, Nuclear receptor subfamily 1 group I member 3, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group B member 1, Nuclear receptor subfamily 3 group C member 1, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), ONR 1, OTTHUMP00000017718, OTTHUMP00000017719, OTTHUMP00000162543, OTTHUMP00000162897, OTTHUMP00000162898, OTTHUMP00000165052, OTTHUMP00000165053, OTTHUMP00000165054, OTTHUMP00000198350, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, Oncogene GLI3, Oncogene JUN, Orphan nuclear receptor MB67, Orphan nuclear receptor NR1I3, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, P 450AROM, P53_HUMAN, P67, PAP A, PAPB, PAR, PAR q, PARP cleavage protease, PPD IV, PRR, Peptidase M, Peptidase M2, Phosphoprotein p53, Pregnane X receptor, Procaspase3, Protein Yama, Proto-oncogene c-jun, RAR related orphan nuclear receptor variant 2, RAR related orphan receptor C, isoform a, RAR related orphan receptor gamma, RAR-related orphan receptor C, RNESTROR, RORG_HUMAN, RP24-311F12.2, RZR GAMMA, RZRG, Retinoic acid binding receptor gamma, Retinoid-related orphan receptor-gamma, Rorc, SBMA, SCA-1, SCAN1, SMAX1, SREBP cleavage activity 1, SRP27, SXR, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), Steroid and xenobiotic receptor, Steroid hormone receptor ERR1, Stress-responsive protein 27, TFM, TOR, TRP53, TYDP, TYDP1_HUMAN, Testicular Feminization (TFM), Tp53, Transcription factor AP-1, Transcriptional activator GLI3, Transcriptional repressor GLI3R, Transformation related protein 53, Tumor protein 53, Tumor protein p53, Tumor suppressor p53, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, V jun sarcoma virus 17 oncogene homolog, V jun sarcoma virus 17 oncogene homolog (avian), V-jun avian sarcoma virus 17 oncogene homolog, WALp4, Yama, Yama protein, Zinc finger protein GLI 3, androgen receptor splice variant 4b, cJun, constitutive active receptor, constitutive androstane nuclear receptor variant 2, constitutive androstane nuclear receptor variant 3, constitutive androstane nuclear receptor variant 4, constitutive androstane nuclear receptor variant 5, epididymis secretory protein Li 102, estrogen receptor related receptor alpha, flavoprotein-linked monooxygenase, glucocorticoid nuclear receptor variant 1, hERR1, hWALp4, heat shock protein family B (small) member 1, mldy, nr3c1, nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor), orphan nuclear hormone receptor, p39, p53 tumor suppressor, p67eIF2, pregnane X nuclear receptor variant 2, tumor antigen p55
MW 145.16 Da, Purity >99%. RNA synthesis inhibitor. Displays antimicrobial activity and also shows chelating properties. Active in vivo.
Soluble in ethanol to 100 mM.
Soluble in DMSO to 100 mM.
RNA synthesis inhibitor. Displays antimicrobial activity and also shows chelating properties. Active in vivo.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab141198, 8-Hydroxyquinoline (8HQ), RNA synthesis inhibitor and ion chelator
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com